Monitoring of Neuromuscular Blockade in the Intensive Care Unit: a Reliability Study
Recruiting
N/A
Interventional Study
Neuromuscular Blockade Monitoring
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 160 (estimated)
- Sponsor
- Centre Hospitalier Intercommunal Aix-Pertuis · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this clinical trial is to evaluate the reliability of neuromuscular blockade monitoring in adult intensive care patients depending on the clinical context.
The main questions it aims to answer are as follows:
* Detection of an anomaly at ulnar "TOF" stimulation in patients without neuromuscular blockade
* Absence of adverse events during clinical monitoring of neuromuscular bloc…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients
* Patients admitted to the intensive care unit who have been receiving neuromuscular blocking agents for at least 24 hours during their stay - Consent obtained from the patient or emergency consent obtained from family members
* Patients covered by the French so…
Contacts
No contact information available.